Overview
- This week researchers at the Skolkovo Institute published a simulation in npj Aging that models a hypothetical population in which all reversible ageing hallmarks are cured except somatic mutations and finds median lifespan falls to roughly 146–194 years.
- The model identifies long‑lived, non‑dividing cells in the brain (neurons) and heart (cardiomyocytes) as the critical bottlenecks because those cells accumulate irreversible mutations without replacement.
- Authors stress the result is a theoretical, assumption‑dependent estimate not experimental proof and that outcomes change sharply if model parameters, organ interactions, or failure thresholds are altered.
- The paper shows extreme, highly unlikely mathematical scenarios can produce far larger upper bounds but emphasizes those numbers are not realistic and should not be read as predictions of imminent longevity breakthroughs.
- The main value of the work is methodological: it quantifies how much somatic mutations alone could limit life and offers a tool to rank and prioritize which ageing mechanisms to target in future research.